Patients with VEXAS diagnosed in a Danish tertiary rheumatology setting have highly elevated inflammatory markers, macrocytic anaemia and negative autoimmune biomarkers.

Mads Nyhuus Bendix RaschFruzsina SzabadosJens Magnus Bernth JensenKirstine Overgaard NielsenEllen-Margrethe HaugeAnne Troldborg

Published in: RMD open (2022)

Danish patients with VEXAS syndrome are men with persistent inflammation, constitutional symptoms and heterogeneous clinical presentations. Shared features for all patients in this study were highly elevated inflammatory markers, macrocytic anaemia and negative autoimmune biomarkers.

Keyphrases

end stage renal disease
multiple sclerosis
chronic kidney disease
ejection fraction
newly diagnosed
oxidative stress
prognostic factors
physical activity
case report